Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-03 09:06 am Unchanged | 2025-10-02 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 14,895 9.990% | 0 (Unchanged) | Filing History |
| 2025-10-02 8:37 pm Sale | 2025-09-30 | 13D | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 14,895 9.990% | -9,143![]() (-38.04%) | Filing History |
| 2025-08-18 5:52 pm Sale | 2025-08-14 | 13D | IGM BIOSCIENCES INC IGMS | Baker Bros. Advisors LP | 0 0.000% | -4,145,706![]() (Position Closed) | Filing History |
| 2025-08-14 4:28 pm Purchase | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Baker Bros. Advisors LP | 7,305,940 6.900% | 1,465,881![]() (+25.10%) | Filing History |
| 2025-08-14 4:27 pm Purchase | 2025-06-30 | 13G | IMMATICS N V IMTX | Baker Bros. Advisors LP | 10,168,901 8.400% | 2,893,071![]() (+39.76%) | Filing History |
| 2025-08-14 4:27 pm Sale | 2025-06-30 | 13G | NEUROGENE INC NGNE | Baker Bros. Advisors LP | 991,804 7.000% | -494,509![]() (-33.27%) | Filing History |
| 2025-08-14 4:26 pm Purchase | 2025-06-30 | 13G | REVOLUTION MEDICINES INC RVMD | Baker Bros. Advisors LP | 9,364,972 5.000% | 9,364,972![]() (New Position) | Filing History |
| 2025-08-14 4:26 pm Sale | 2025-06-30 | 13G | CERUS CORP CERS | Baker Bros. Advisors LP | 12,903,708 6.800% | -6,593,495![]() (-33.82%) | Filing History |
| 2025-08-01 5:41 pm Purchase | 2025-08-01 | 13D | CELCUITY INC CELC | Baker Bros. Advisors LP | 7,745,692 18.900% | 3,487,957![]() (+81.92%) | Filing History |
| 2025-06-30 8:26 pm Purchase | 2025-06-26 | 13D | KYMERA THERAPEUTICS INC KYMR | Baker Bros. Advisors LP | 6,666,540 9.500% | 665,278![]() (+11.09%) | Filing History |
| 2025-06-13 5:21 pm Purchase | 2025-06-12 | 13D | PRELUDE THERAPEUTICS INC PRLD | Baker Bros. Advisors LP | 10,269,968 23.500% | 47,000![]() (+0.46%) | Filing History |
| 2025-05-15 4:33 pm Sale | 2025-03-31 | 13G | CANDEL THERAPEUTICS INC CADL | Baker Bros. Advisors LP | 2,455,108 4.990% | -526,875![]() (-17.67%) | Filing History |
| 2025-05-15 4:19 pm Purchase | 2025-03-31 | 13G | NEUROGENE INC NGNE | Baker Bros. Advisors LP | 1,486,313 9.960% | 836,628![]() (+128.77%) | Filing History |
| 2025-05-15 4:19 pm Sale | 2025-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Baker Bros. Advisors LP | 5,604,483 8.900% | -793,882![]() (-12.41%) | Filing History |
| 2025-04-07 7:04 pm Purchase | 2025-03-31 | 13G | CELCUITY INC CELC | Baker Bros. Advisors LP | 4,257,735 11.300% | 1,579,182![]() (+58.96%) | Filing History |
| 2025-03-31 7:35 pm Purchase | 2025-03-27 | 13D | DBV TECHNOLOGIES S.A. ADR DBVT | Baker Bros. Advisors LP | 23,489,663 17.100% | 21,140,696![]() (+900.00%) | Filing History |
| 2025-03-07 5:07 pm Unchanged | 2025-03-07 | 13D | REPLIMUNE GROUP INC REPL | Baker Bros. Advisors LP | 11,045,336 14.300% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:33 pm Purchase | 2025-02-12 | 13D | SERA PROGNOSTICS INC SERA | Baker Bros. Advisors LP | 5,498,170 16.100% | 63,771![]() (+1.17%) | Filing History |
| 2025-02-14 4:16 pm Purchase | 2024-12-31 | 13G | IMMATICS N V IMTX | Baker Bros. Advisors LP | 7,275,830 6.000% | 1,436,977![]() (+24.61%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | CELCUITY INC CELC | Baker Bros. Advisors LP | 2,678,553 7.200% | 803,575![]() (+42.86%) | Filing History |

